glp 1 types of drugs New GLP-1 Guidelines for Type 2 Diabetes in 2025 Press Release Page | Press
Description
Beyond these established indications, accumulating evidence suggests that GLP-1 RAs exert pleiotropic effects on immune regulation, inflammation, and tissue remodelingpathways highly relevant to dermatological and surgical disciplines [1,2,3,4,5]
Given that both SGLT2i and GLP-1 RA demonstrate robust and consistent cardio-renal benefits [14], both agents seem to be an attractive option to fulfil an unmet therapeutic need in type 1 diabetes
In a study using the GLP-1R agonist liraglutide, its ability to reverse cognitive deficits in an AD model and its potential neuroprotective mechanisms were identified
The gastrointestinal side effects common with GLP-1 medications compound this problem significantly
